Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DMPK inhibitors(DM1 protein kinase inhibitors), MNK1 inhibitors(MAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization 4e Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | US | 4e Therapeutics, Inc.Startup | - |